Cargando…

Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program

PURPOSE: Since 2004, the National Cancer Screening Program of Korea has included colorectal cancer screening based on primary screening with the fecal occult blood test (FOBT). We report on the clinical features of colorectal cancer detected by the National Cancer Screening Program. METHODS: We retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dae-Do, Shin, Rumi, Kim, Ji-Sun, Oh, Heung-Kwon, Jeong, Seung-Yong, Park, Kyu Joo, Park, Jae-Gahb
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Coloproctology 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017978/
https://www.ncbi.nlm.nih.gov/pubmed/21221243
http://dx.doi.org/10.3393/jksc.2010.26.6.420
_version_ 1782195998155603968
author Park, Dae-Do
Shin, Rumi
Kim, Ji-Sun
Oh, Heung-Kwon
Jeong, Seung-Yong
Park, Kyu Joo
Park, Jae-Gahb
author_facet Park, Dae-Do
Shin, Rumi
Kim, Ji-Sun
Oh, Heung-Kwon
Jeong, Seung-Yong
Park, Kyu Joo
Park, Jae-Gahb
author_sort Park, Dae-Do
collection PubMed
description PURPOSE: Since 2004, the National Cancer Screening Program of Korea has included colorectal cancer screening based on primary screening with the fecal occult blood test (FOBT). We report on the clinical features of colorectal cancer detected by the National Cancer Screening Program. METHODS: We retrospectively analyzed 577 patients who underwent elective surgery for colorectal cancer at the Seoul National University Hospital between January 2008 and December 2009. We compared the clinical features of colorectal cancers detected by the National Cancer Screening Program (NCSP group) with those of the control group in terms of age, gender, preoperative symptom, location of the tumor, surgical technique and tumor-node-metastasis (TNM) stage. RESULTS: Age, gender, location of the tumor and operation types were not different between the two groups. The proportion of asymptomatic patients was significantly higher in the NCSP group than it was in the control group (86.5% vs. 20.0%; P < 0.001). The proportion of less invasive lesions (T1 or T2) was significantly higher in the NCSP group (46.3% vs. 27.7%; P = 0.002). The pathologic stages of the colorectal cancers in the NCSP group were I, 40.3%; II, 17.9%; III, 40.3% and IV, 1.5% whereas in the control group, they were I, 20.8%; II, 32.9%; III, 34.9% and IV, 11.4%. The proportion of stage I cancer was significantly higher in the NCSP group than in the control group (40.3% vs. 20.8%; P = 0.006). CONCLUSION: Our study demonstrates the FOBT in the NCSP is effective in early detection of colorectal cancer.
format Text
id pubmed-3017978
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Korean Society of Coloproctology
record_format MEDLINE/PubMed
spelling pubmed-30179782011-01-10 Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program Park, Dae-Do Shin, Rumi Kim, Ji-Sun Oh, Heung-Kwon Jeong, Seung-Yong Park, Kyu Joo Park, Jae-Gahb J Korean Soc Coloproctology Original Article PURPOSE: Since 2004, the National Cancer Screening Program of Korea has included colorectal cancer screening based on primary screening with the fecal occult blood test (FOBT). We report on the clinical features of colorectal cancer detected by the National Cancer Screening Program. METHODS: We retrospectively analyzed 577 patients who underwent elective surgery for colorectal cancer at the Seoul National University Hospital between January 2008 and December 2009. We compared the clinical features of colorectal cancers detected by the National Cancer Screening Program (NCSP group) with those of the control group in terms of age, gender, preoperative symptom, location of the tumor, surgical technique and tumor-node-metastasis (TNM) stage. RESULTS: Age, gender, location of the tumor and operation types were not different between the two groups. The proportion of asymptomatic patients was significantly higher in the NCSP group than it was in the control group (86.5% vs. 20.0%; P < 0.001). The proportion of less invasive lesions (T1 or T2) was significantly higher in the NCSP group (46.3% vs. 27.7%; P = 0.002). The pathologic stages of the colorectal cancers in the NCSP group were I, 40.3%; II, 17.9%; III, 40.3% and IV, 1.5% whereas in the control group, they were I, 20.8%; II, 32.9%; III, 34.9% and IV, 11.4%. The proportion of stage I cancer was significantly higher in the NCSP group than in the control group (40.3% vs. 20.8%; P = 0.006). CONCLUSION: Our study demonstrates the FOBT in the NCSP is effective in early detection of colorectal cancer. The Korean Society of Coloproctology 2010-12 2010-12-31 /pmc/articles/PMC3017978/ /pubmed/21221243 http://dx.doi.org/10.3393/jksc.2010.26.6.420 Text en © 2010 The Korean Society of Coloproctology http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Dae-Do
Shin, Rumi
Kim, Ji-Sun
Oh, Heung-Kwon
Jeong, Seung-Yong
Park, Kyu Joo
Park, Jae-Gahb
Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title_full Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title_fullStr Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title_full_unstemmed Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title_short Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
title_sort clinical features of colorectal cancer detected by the national cancer screening program
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017978/
https://www.ncbi.nlm.nih.gov/pubmed/21221243
http://dx.doi.org/10.3393/jksc.2010.26.6.420
work_keys_str_mv AT parkdaedo clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT shinrumi clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT kimjisun clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT ohheungkwon clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT jeongseungyong clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT parkkyujoo clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram
AT parkjaegahb clinicalfeaturesofcolorectalcancerdetectedbythenationalcancerscreeningprogram